Overcoming HIV Drug Resistance

Technology licensed to startup Aldatu Biosciences may be a powerful tool for clinicians treating HIV in developing nations

Getting to Zero

“If you can identify resistance early and switch patients to the right drugs, you can reduce new infections,” says David Raiser (left), PhD ’15, CEO of Aldatu. X

Restoring Mobility

Collaboration with ReWalk Robotics to develop wearable exosuits for people with lower-limb disabilities

Soft and Lightweight

"Ultimately this agreement paves the way for this technology to make its way to patients," says Prof. Conor Walsh. X

Solving an Agricultural Challenge

Successful demonstration of protein evolution technology helps tackle pesticide resistance

Health Care Applications

The PACE platform could also accelerate the discovery of new therapeutic proteins. X

Reimagining Women's Health

Two Harvard-trained researchers are developing a smart tampon system to monitor health and fertility

Privacy and Agency

Ridhi Tariyal, MBA '09, and Stephen Gire want to put actionable health information into women’s hands, before it's too late. X

Advancing Cancer Treatment

Major license agreement with Merck advances novel compounds developed through Blavatnik Biomedical Accelerator

Much-Needed Therapy

The collaboration with Merck aims to address acute myeloid leukemia, the most common form of acute leukemia. (Image credit: NCI.) X